How can clinical trials be made above reproach? How can a healthcare professional best interpret the results of clinical trials? Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic and past-president of the American College of Cardiology, joins Host Dr. Martin A. Samuels to discuss these and other topics
Making Clinical Trials More Relevant
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
How can clinical trials be made above reproach? How can a healthcare professional best interpret the results of clinical trials? Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic and past-president of the American College of Cardiology, joins Host Dr. Martin A. Samuels to discuss these and other topics
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?